SCHEMBL22906223

SCHEMBL22906223

C[C@@H]1C=NN(c2ccccc2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.38
GAA P10253 4/20 0.38
G6PD P11413 1/20 0.38
MAPT P10636 5/20 0.35
RAB9A P51151 3/20 0.35
MAPK1 P28482 3/20 0.35
KDM4E B2RXH2 3/20 0.35
NPC1 O15118 2/20 0.35
GLA P06280 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 4/20 0.35
ALOX5 P09917 2/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923533 1.00 L3MBTL1 (0.38) L3MBTL1GAAG6PDMAPTRAB9A
SCHEMBL4799037 0.80 NAPRT (0.32) MAPTKDM4EMAOB
SCHEMBL19391639 0.79 ALOX5 (0.44) GAAMAPTKDM4EALOX5MEN1
SCHEMBL19507158 0.76 MAPT (0.35) L3MBTL1GAAG6PDMAPTRAB9A
SCHEMBL14275214 0.74 MAPT (0.34) L3MBTL1GAAMAPTRAB9AMAPK1
SCHEMBL22055640 0.74 SMN1; SMN2 (0.40) MAPTMAPK1KDM4EALDH1A1USP2
SCHEMBL17677339 0.65 KDM4E (0.39) L3MBTL1GAAKDM4EALDH1A1USP2
SCHEMBL7719928 0.65 L3MBTL1 (0.40) L3MBTL1GAAG6PDMAPTRAB9A
SCHEMBL11050112 0.65 ALDH1A1 (0.46) L3MBTL1GAAG6PDMAPTRAB9A
SCHEMBL972562 0.65 L3MBTL1 (0.43) L3MBTL1GAAG6PDMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020006423-A9 SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO EDITAS MEDICINE, INC. (US) 2021-01-21 WO disclosed